Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 51:1349-1356, doi:10.1016/j.jacc.2007.12.033
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dworakowski, R.
Right arrow Articles by Shah, A. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dworakowski, R.
Right arrow Articles by Shah, A. M.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH: HEART FAILURE

Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Derived Superoxide and Vascular Endothelial Dysfunction in Human Heart Failure

Rafal Dworakowski, MD, PhD*, Simon Walker*, Aziz Momin, FRCS*, Jatin Desai, FRCS*, Ahmed El-Gamel, FRCS*, Olaf Wendler, MD, PhD*, Mark T. Kearney, MD, FRCP{dagger} and Ajay M. Shah, MD, FMedSci*,*

* Cardiovascular Division, King’s College London School of Medicine, London, United Kingdom
{dagger} Leeds Institute for Genetics, Health and Therapeuticss, University of Leeds, Leeds, United Kingdom.

Manuscript received October 1, 2007; revised manuscript received December 12, 2007, accepted December 17, 2007.

* Reprint requests and correspondence: Prof. Ajay M. Shah, Cardiovascular Division, James Black Centre, King’s College London, 125 Coldharbour Lane, London SE5 9NU, U.K. (Email: ajay.shah{at}kcl.ac.uk).

Objectives: We investigated the role of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in endothelial dysfunction in human heart failure.

Background: Vascular endothelial dysfunction in human heart failure contributes to increased tone, exercise limitation, and dysregulation of venous capacitance and vascular volume. The NADPH oxidases (Nox) are an important source of oxidative stress, but their role in the endothelial dysfunction of human heart failure remains unknown.

Methods: Endothelium-dependent and -independent vasorelaxation were assessed in saphenous vein segments obtained from consecutive patients with heart failure (n = 19) or normal left ventricular function (control; n = 35) undergoing coronary artery bypass graft. Saphenous vein superoxide production was measured by lucigenin-enhanced chemiluminescence and messenger ribonucleic acid expression of relevant transcripts quantified by real-time polymerase chain reaction.

Results: Heart failure patients had significantly worse endothelial function than control subjects (15.2 ± 3% vs. 40.5 ± 8.4% relative relaxation; p < 0.05), elevated C-reactive protein (CRP) levels (8.6 ± 2.7 mg/l vs. 2.6 ± 0.4 mg/l; p < 0.05), over 2-fold higher NADPH-dependent superoxide generation (p < 0.05), and significantly higher expression of the Nox4 isoform and regulatory subunit p67phox. Superoxide levels were positively correlated with New York Heart Association functional class (r = 0.684; p < 0.05) and CRP (r = 0.501; p < 0.005; n = 32).

Conclusions: Venous endothelial dysfunction in human heart failure is associated with increased Nox-derived superoxide generation. Inflammatory mechanisms may be involved in the increased reactive oxygen species generation.

Abbreviations and Acronyms
  CABG = coronary artery bypass graft
  CHF = chronic heart failure
  CRP = C-reactive protein
  DPI = diphenyleneiodonium
  EF = ejection fraction
  IL = interleukin
  LV = left ventricle/ventricular
  NADPH = nicotinamide adenine dinucleotide phosphate
  NO = nitric oxide
  NOS = nitric oxide synthase
  Nox = nicotinamide adenine dinucleotide phosphate oxidase(s)
  ROS = reactive oxygen species
  SNP = sodium nitroprusside
  TNF = tumor necrosis factor


Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 51: A33-A34. [Full Text] [PDF]





 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement